发明名称 |
INHALATION COMPOSITION CONTAINING ACLIDINIUM FOR TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
摘要 |
<p>Disclosed herein is a pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a metered nominal dose of aclidinium equivalent to about 200 micrograms aclidinium bromide, said compositions can further comprise an effective amount of one or more addititional active agents selected from beta2-agonists, PDE IV inhibitors and corticosteroids. Also disclosed is the use of aclidinium in free or pharmaceutically acceptable salt form in the manufacture of a medicament for treating a respiratory condition selected from asthma and chronic obstructive pulmonary disease in a patient in need of such treatment, said use comprising administering a single or twice daily metered nominal dose of aclidinium equivalent to about 200 micrograms aclidinium bromide.</p> |
申请公布号 |
NZ585856(A) |
申请公布日期 |
2012.09.28 |
申请号 |
NZ20090585856 |
申请日期 |
2009.03.13 |
申请人 |
ALMIRALL, S.A. |
发明人 |
LAMARCA CASADO, ROSA;DE MIQUEL SERRA, GONZALO |
分类号 |
A61K9/14;A61K9/72;A61K31/46;A61K45/06 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|